Alligator Bioscience, Stanford Expand Immuno-Oncology Collaboration

Alligator Bioscience, Stanford Expand Immuno-Oncology Collaboration

HTTP/1.1 200 OK Date: Tue, 08 Aug 2017 08:33:08 GMT Content-Type: text/html; charset=utf-8 Transfer-Encoding: chunked Connection: keep-alive Cache-Control: no-cache, must-revalidate Content-Language: en Expires: Sun, 19 Nov 1978 05:00:00 GMT Link: ; rel="canonical",; rel="shortlink" Surrogate-Key: yhzG1o7SVGs+GcuqK5Xk OuhNSWugB2Lyc7UlasEl Surrogate-Key-Raw: X-Content-Type-Options: nosniff X-Drupal-Cache: MISS X-Frame-Options: SAMEORIGIN X-Pantheon-Environment: live X-Pantheon-Phpreq: yes X-Pantheon-Site: 025e433e-4745-4e86-bd6a-9fb252581f65 X-Pantheon-Styx-Hostname: styx480365c9 X-Styx-Req-Id: styx-553eb2060a47d38dbd8c466c72e66e76 xkey: yhzG1o7SVGs+GcuqK5Xk OuhNSWugB2Lyc7UlasEl X-Varnish: 321513803 Age: 0 Via: 1.1 varnish-v4 Vary: Accept-Encoding, Cookie Server: cloudflare-nginx CF-RAY: 38b12109eab75570-ORD Alligator Bioscience, Stanford Expand Immuno-Oncology Collaboration | GenomeWeb

NEW YORK (GenomeWeb) – Swedish biotech firm Alligator Bioscience has expanded a collaboration with Stanford University in the area of immuno-oncology biomarker discovery.

As part of the agreement, the partners aim to enable the early prediction of clinical efficacy of Alligator's pipeline candidates by analyzing potential systemic biomarkers, which may eventually benefit patients through appropriate treatment selection based on biomarker analysis.

Get the full story

This story is free
for registered users

How To Become A Good Essay Writer Registering provides access to this and other free content.

History Homework Help Ks3

Already have an account?
.

Travel And Tourism Coursework Help Read more